1279822-48-8 Usage
Uses
Used in Pharmaceutical Industry:
1-(2-chloropyrimidin-5-yl)ethanol is used as a building block for the synthesis of various pharmaceuticals, contributing to the development of new drugs with improved therapeutic properties. Its unique chemical structure allows for the creation of novel compounds with potential medicinal applications.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(2-chloropyrimidin-5-yl)ethanol is employed as a key component in the synthesis of agrochemicals, such as pesticides and herbicides. Its incorporation into these products can enhance their effectiveness in controlling pests and weeds, thereby improving crop yields and quality.
Used as a Reagent in Chemical Reactions:
1-(2-chloropyrimidin-5-yl)ethanol is utilized as a reagent to introduce the 2-chloropyrimidin-5-yl group into other molecules, expanding the range of chemical reactions and products that can be synthesized. This capability is particularly valuable in the development of new compounds with specific properties and applications.
Used in Drug Development Research:
1-(2-chloropyrimidin-5-yl)ethanol is being studied for its potential biological activity, with the aim of discovering its use as a drug or a precursor in drug development. Its unique structure and properties make it a promising candidate for further research and development in the pharmaceutical field.
Check Digit Verification of cas no
The CAS Registry Mumber 1279822-48-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,7,9,8,2 and 2 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1279822-48:
(9*1)+(8*2)+(7*7)+(6*9)+(5*8)+(4*2)+(3*2)+(2*4)+(1*8)=198
198 % 10 = 8
So 1279822-48-8 is a valid CAS Registry Number.
1279822-48-8Relevant academic research and scientific papers
PCSK9 INHIBITORS AND METHODS OF USE THEREOF
-
Page/Page column 230, (2020/07/31)
The invention relates to a novel inhibitor pharmacophore of PCSK9 and heteroaryl compounds that bind the PCSK9 protein.
PCSK9 INHIBITORS AND METHODS OF USE THEREOF
-
Page/Page column 221, (2020/07/31)
The invention relates to novel heteroaryl compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cardiovascular diseases, and methods treating sepsis or septic shock, using the novel heterocyclic compounds disclosed herein.
ISOQUINOLINE DERIVATIVES AS MGAT2 INHIBITORS
-
Paragraph 0320; 0321, (2018/02/27)
The compounds of Formula I act as MGAT2 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.
cGAS ANTAGONIST COMPOUNDS
-
Paragraph 0216; 0225; 0308, (2017/11/06)
Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
